Inflammatory breast cancer.

Authors

  • Maria V Valsassina Instituto Português de Oncologia de Francisco Gentil, Lisboa.

DOI:

https://doi.org/10.20344/amp.1977

Abstract

The inflammatory breast cancer corresponds to 1-6% of breast tumors. It is an aggressive clinical entity being characterised by the incidence of local relapse and distant metastases superior to the other breast malign entities. Changes in its therapy have been observed: progressive innovating therapeutic strategies have been adopted, tendentiously multimodal ones, trying to alter the course of this pathology of such a unfavourable prognosis. Here we show a revision of the most significant facts in the evolution of the inflammatory breast carcinoma diagnosis and treatment, both as to the present development and future perspectives. Aspects of clinical diagnosis are emphasized as well as their corroboration with complementary diagnosis technics and their evolution before different approaching therapies.

Downloads

Download data is not yet available.

How to Cite

1.
Valsassina MV. Inflammatory breast cancer. Acta Med Port [Internet]. 2002 Dec. 31 [cited 2024 Nov. 12];15(6):461-4. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/1977

Issue

Section

Arquivo Histórico